HK1120089A1 - Gene expression markers for colorectal cancer prognosis - Google Patents

Gene expression markers for colorectal cancer prognosis

Info

Publication number
HK1120089A1
HK1120089A1 HK09100394.3A HK09100394A HK1120089A1 HK 1120089 A1 HK1120089 A1 HK 1120089A1 HK 09100394 A HK09100394 A HK 09100394A HK 1120089 A1 HK1120089 A1 HK 1120089A1
Authority
HK
Hong Kong
Prior art keywords
gene expression
colorectal cancer
cancer prognosis
expression markers
markers
Prior art date
Application number
HK09100394.3A
Other languages
English (en)
Chinese (zh)
Inventor
Wayne Cowens
Joffre B Baker
Kim Clark
James Hackett
Drew Watson
Soonmyung Paik
Original Assignee
Genomic Health Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genomic Health Inc filed Critical Genomic Health Inc
Publication of HK1120089A1 publication Critical patent/HK1120089A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57419—Specifically defined cancers of colon
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57446—Specifically defined cancers of stomach or intestine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
HK09100394.3A 2006-01-11 2009-01-15 Gene expression markers for colorectal cancer prognosis HK1120089A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US75839206P 2006-01-11 2006-01-11
US80027706P 2006-05-12 2006-05-12
US81007706P 2006-05-31 2006-05-31
PCT/US2007/000995 WO2007082099A2 (en) 2006-01-11 2007-01-11 Gene expression markers for colorectal cancer prognosis

Publications (1)

Publication Number Publication Date
HK1120089A1 true HK1120089A1 (en) 2009-03-20

Family

ID=38257063

Family Applications (1)

Application Number Title Priority Date Filing Date
HK09100394.3A HK1120089A1 (en) 2006-01-11 2009-01-15 Gene expression markers for colorectal cancer prognosis

Country Status (15)

Country Link
US (10) US7695913B2 (ja)
EP (9) EP2412824B1 (ja)
JP (7) JP5297202B2 (ja)
KR (1) KR20090003178A (ja)
AU (1) AU2007204826B2 (ja)
BR (1) BRPI0706511A2 (ja)
CA (1) CA2636984A1 (ja)
DK (1) DK1974058T3 (ja)
ES (1) ES2491222T3 (ja)
HK (1) HK1120089A1 (ja)
IL (1) IL192794A (ja)
MX (1) MX2008008973A (ja)
NO (1) NO20083461L (ja)
NZ (7) NZ593228A (ja)
WO (1) WO2007082099A2 (ja)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8008003B2 (en) 2002-11-15 2011-08-30 Genomic Health, Inc. Gene expression profiling of EGFR positive cancer
EP2163650B1 (en) 2004-04-09 2015-08-05 Genomic Health, Inc. Gene expression markers for predicting response to chemotherapy
NZ593228A (en) 2006-01-11 2012-10-26 Genomic Health Inc Gene expression markers (inhba) for colorectal cancer prognosis
US8700335B2 (en) 2006-05-18 2014-04-15 Caris Mpi, Inc. System and method for determining individualized medical intervention for a disease state
US8768629B2 (en) * 2009-02-11 2014-07-01 Caris Mpi, Inc. Molecular profiling of tumors
US20090076734A1 (en) 2007-03-22 2009-03-19 Torres-Roca Javier F Gene Signature for the Prediction of Radiation Therapy Response
US20080234946A1 (en) * 2007-03-22 2008-09-25 University Of South Florida Predictive radiosensitivity network model
DK2140269T3 (da) 2007-03-27 2013-12-16 Immunovia Ab Proteinsignatur/markører til at detektere adenocarcinom
US20090123920A1 (en) * 2007-11-08 2009-05-14 Maher Albitar Jak2 mutations
ES2332167B1 (es) * 2007-12-04 2010-10-25 Universidad Autonoma De Madrid Empleo de trefoil factor-family 3 (tff3) en el pronostico de sujetos diagnosticados con cancer colorectal.
WO2009123634A1 (en) * 2008-04-02 2009-10-08 Regents Of The University Of California Systems and methods for predicting response of biological samples
WO2009114836A1 (en) * 2008-03-14 2009-09-17 Genomic Health, Inc. Gene expression markers for prediction of patient response to chemotherapy
NZ597292A (en) 2008-05-14 2013-06-28 Genomic Health Inc Use of PTP4A3 to predict a patient's response to treatment with an EGF receptor inhibitor
US20100029748A1 (en) * 2008-08-04 2010-02-04 Sloan-Kettering Institute For Cancer Research Metastasis Promoting Genes and Proteins
US10359425B2 (en) * 2008-09-09 2019-07-23 Somalogic, Inc. Lung cancer biomarkers and uses thereof
US20100221752A2 (en) * 2008-10-06 2010-09-02 Somalogic, Inc. Ovarian Cancer Biomarkers and Uses Thereof
WO2010042228A2 (en) * 2008-10-10 2010-04-15 Cornell University Methods for predicting disease outcome in patients with colon cancer
US20120041274A1 (en) 2010-01-07 2012-02-16 Myriad Genetics, Incorporated Cancer biomarkers
US8765383B2 (en) * 2009-04-07 2014-07-01 Genomic Health, Inc. Methods of predicting cancer risk using gene expression in premalignant tissue
SG175832A1 (en) * 2009-05-01 2011-12-29 Genomic Health Inc Gene expression profile algorithm and test for likelihood of recurrence of colorectal cancer and response to chemotherapy
TWI513465B (zh) * 2009-06-25 2015-12-21 Regeneron Pharma 以ｄｌｌ４拮抗劑與化學治療劑治療癌症之方法
CA2804391A1 (en) 2010-07-07 2012-01-12 Myriad Genetics, Inc. Gene signatures for cancer prognosis
MX355020B (es) 2010-07-09 2018-04-02 Somalogic Inc Biomarcadores de cancer de pulmon y usos de los mismos.
MX346031B (es) 2010-07-27 2017-03-01 Genomic Health Inc Método para emplear expresión génica para determinar pronóstico de cáncer de próstata.
CN106198980B (zh) 2010-08-13 2018-09-07 私募蛋白质体公司 胰腺癌生物标记及其用途
US9605319B2 (en) 2010-08-30 2017-03-28 Myriad Genetics, Inc. Gene signatures for cancer diagnosis and prognosis
SG10201610027VA (en) 2010-09-15 2017-01-27 Almac Diagnostics Ltd Molecular diagnostic test for cancer
WO2012103250A2 (en) * 2011-01-25 2012-08-02 Almac Diagnostics Limited Colon cancer gene expression signatures and methods of use
EP2773772A1 (en) * 2011-11-04 2014-09-10 Oslo Universitetssykehus HF Methods and biomarkers for analysis of colorectal cancer
EP2785861B1 (en) 2011-11-28 2020-01-15 Institució Catalana de Recerca i Estudis Avançats Methods and kits for the prognosis of colorectal cancer
US10519506B2 (en) 2011-12-22 2019-12-31 Baylor Research Institute Identification of metastasis-specific miRNA and hypomethylation signatures in human colorectal cancer
AU2013208757A1 (en) 2012-01-09 2014-07-24 Oslo Universitetssykehus Hf Methods and biomarkers for analysis of colorectal cancer
NZ722902A (en) 2012-01-31 2017-12-22 Genomic Health Inc Gene expression profile algorithm and test for determining prognosis of prostate cancer
WO2013150167A2 (es) 2012-04-03 2013-10-10 Servicio Andaluz De Salud Modelo de expresión de microarn como indicador de supervivencia en pacientes de cancer colorrectal metastásico
WO2014077915A1 (en) * 2012-11-14 2014-05-22 Mayo Foundation For Medical Education And Research Methods and materials for identifying malignant skin lesions
WO2014078700A1 (en) 2012-11-16 2014-05-22 Myriad Genetics, Inc. Gene signatures for cancer prognosis
ES2475366B1 (es) * 2012-12-10 2015-05-05 Fundación Imdea Alimentación Métodos y kits para el pronóstico del cáncer colorrectal
US9994908B2 (en) 2013-03-14 2018-06-12 Abbott Molecular Inc. Materials and methods for assessment of colorectal adenoma
AR096507A1 (es) * 2013-05-30 2016-01-13 Fundació Institució Catalana De Recerca I Estudis Avançats Métodos y kits para el pronóstico del cáncer colorrectal
US10185809B1 (en) * 2013-10-15 2019-01-22 Iqvia Inc. Patient projection methodology
GB201319878D0 (en) * 2013-11-11 2013-12-25 Immunovia Ab Method, Array and use thereof
WO2015149030A1 (en) * 2014-03-28 2015-10-01 Applied Proteomics, Inc. Protein biomarker profiles for detecting colorectal tumors
WO2015175692A1 (en) 2014-05-13 2015-11-19 Myriad Genetics, Inc. Gene signatures for cancer prognosis
WO2016025717A1 (en) 2014-08-14 2016-02-18 Mayo Foundation For Medical Education And Research Methods and materials for identifying metastatic malignant skin lesions and treating skin cancer
ES2857953T3 (es) 2014-10-24 2021-09-29 Koninklijke Philips Nv Pronóstico médico y predicción de la respuesta al tratamiento usando las actividades de múltiples rutas de señalización celular
BR112017007965A8 (pt) 2014-10-24 2022-11-08 Koninklijke Philips Nv Método implantado por computador para inferir a atividade de uma via de sinalização celular de tgf-b em um indivíduo; aparelho para inferir a atividade de uma via de sinalização celular de tgf-b em um indivíduo; meio de armazenamento não transitório; programa de computador; kits para medir níveis de expressão de três ou mais genes-alvo da via de sinalização celular de tgf-b em uma amostra de um indivíduo; inferir a atividade de uma via de sinalização celular de tgf-b em um indivíduo; inferir a atividade de uma via de sinalização celular de tgf-b em um indivíduo; e uso do kit
EP3210144B1 (en) 2014-10-24 2020-10-21 Koninklijke Philips N.V. Medical prognosis and prediction of treatment response using multiple cellular signaling pathway activities
US10100851B2 (en) 2014-11-25 2018-10-16 Mitsubishi Electric Corporation Pneumatic actuator
WO2016089928A1 (en) * 2014-12-01 2016-06-09 Weitz Andrew C Methods for treating and assessing tumor invasion and metastasis
EP3073268A1 (en) * 2015-03-27 2016-09-28 Deutsches Krebsforschungszentrum Stiftung des Öffentlichen Rechts Biomarker panel for diagnosing cancer
CA2982169A1 (en) 2015-04-10 2016-10-13 Applied Proteomics, Inc. Protein biomarker panels for detecting colorectal cancer and advanced adenoma
WO2016208776A1 (ja) * 2015-06-25 2016-12-29 株式会社国際電気通信基礎技術研究所 多器官連関システムを基盤とした予測装置、及び予測プログラム
CA2995520A1 (en) 2015-08-14 2017-02-23 Hendrik Jan VAN OOIJEN Assessment of nfkb cellular signaling pathway activity using mathematical modelling of target gene expression
JP6332780B2 (ja) 2016-03-29 2018-05-30 株式会社国際電気通信基礎技術研究所 医薬組成物又は食品組成物、及び有効成分の体内での効果の評価方法
BR112018073014A2 (pt) 2016-05-10 2019-02-19 Mayo Foundation For Medical Education And Research métodos e materiais para estadiamento e tratamento de câncer de pele
US11746381B2 (en) 2017-03-10 2023-09-05 Cancer Diagnostics Research Innvovations, LLC Methods for diagnosing and treating gastric cancer using miRNA expression
WO2018224731A1 (en) * 2017-06-05 2018-12-13 Ls Cancerdiag Oy A method for determining whether a subject is at risk to develop cancer and tools related thereto
EP3461915A1 (en) 2017-10-02 2019-04-03 Koninklijke Philips N.V. Assessment of jak-stat1/2 cellular signaling pathway activity using mathematical modelling of target gene expression
EP3502279A1 (en) 2017-12-20 2019-06-26 Koninklijke Philips N.V. Assessment of mapk-ap 1 cellular signaling pathway activity using mathematical modelling of target gene expression
JP7027179B2 (ja) * 2018-01-24 2022-03-01 キヤノン株式会社 給送回転体、シート給送装置及び画像形成装置
AU2019230200A1 (en) 2018-03-08 2020-10-29 University Of Notre Dame Du Lac Systems and methods for assessing colorectal cancer molecular subtype and risk of recurrence and for determining and administering treatment protocols based thereon
KR102007450B1 (ko) * 2018-05-31 2019-08-05 한국과학기술연구원 대장암 치료제 발굴을 위한 신규 표적 치료 작용점의 스크리닝 방법 및 이를 이용하여 선별한 대장암 치료 예후 바이오마커
EP3886809A4 (en) 2018-11-28 2022-03-30 Genascence Corporation METHODS AND COMPOSITIONS FOR THE TREATMENT OF OSTEOARTHRITIS
WO2020123699A1 (en) * 2018-12-11 2020-06-18 The Trustees Of Columbia University In The City Of New York Compounds and compositions that cause mycn and/or cmyc degradation and methods of use thereof
CN110257518B (zh) * 2019-07-01 2022-08-02 复旦大学附属中山医院 一种用于预测转移性结直肠癌转化治疗疗效的基因集
KR102263984B1 (ko) * 2020-02-21 2021-06-11 재단법인 아산사회복지재단 직장암 환자에서 수술-전 화학방사선치료의 반응을 예측하기 위한 분석방법
KR102535150B1 (ko) * 2020-04-14 2023-05-23 주식회사 베르티스 암의 예후 예측용 조성물
WO2021222220A2 (en) * 2020-04-29 2021-11-04 Freenome Holdings, Inc. Rna markers and methods for identifying colon cell proliferative disorders
GB202010970D0 (en) 2020-07-16 2020-09-02 Immunovia Ab Methods, arrays and uses thereof
CN112322730B (zh) * 2020-10-16 2023-04-18 上海市第一人民医院 预测肿瘤耐药、复发的标志物kifc1及其抑制剂和应用
EP4026918A1 (en) 2021-01-12 2022-07-13 Koninklijke Philips N.V. Prediction of an outcome of a colorectal cancer subject
CN113667673B (zh) * 2021-07-15 2024-02-06 武汉血液中心 一种类孟买血型FUT1 236delG等位基因及其检测方法和应用
KR20230059642A (ko) * 2021-10-26 2023-05-03 사회복지법인 삼성생명공익재단 miRNA를 포함하는 대장암의 치료 및 전이 억제용 조성물 및 이의 용도
WO2024035653A1 (en) * 2022-08-06 2024-02-15 H. Lee Moffitt Cancer Center And Research Institute, Inc. Predictive biomarker in avastin in colon cancer

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020172987A1 (en) 1998-02-12 2002-11-21 Terstappen Leon W.M.M. Methods and reagents for the rapid and efficient isolation of circulating cancer cells
WO1999064627A2 (en) 1998-06-06 1999-12-16 Genostic Pharma Limited Probes used for genetic profiling
GB2339200B (en) 1998-06-06 2001-09-12 Genostic Pharma Ltd Genostics
JP5213202B2 (ja) 1998-10-28 2013-06-19 バイシス・インコーポレーテツド 細胞アレイならびに遺伝障害マーカーの検出および使用方法
EP0999016B1 (en) * 1998-11-06 2001-07-11 Temco S. R. L. Cutter for cross cutting of webs
US6692916B2 (en) 1999-06-28 2004-02-17 Source Precision Medicine, Inc. Systems and methods for characterizing a biological condition or agent using precision gene expression profiles
US6960439B2 (en) 1999-06-28 2005-11-01 Source Precision Medicine, Inc. Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles
EP1265582A2 (en) 1999-09-29 2002-12-18 Human Genome Sciences, Inc. Colon and colon cancer associated polynucleotides and polypeptides
AU2088801A (en) 1999-12-10 2001-06-18 Dana-Farber Cancer Institute, Inc. Metastasis genes and uses thereof
US7029677B2 (en) * 2000-01-25 2006-04-18 Nuvelo, Inc. Methods of therapy and diagnosis using immunotargeting of CD84Hy1-expressing cells
EP1278893A2 (en) 2000-04-06 2003-01-29 Epigenomics AG Diagnosis of diseases associated with dna replication
WO2005000087A2 (en) 2003-06-03 2005-01-06 Chiron Corporation Gene products differentially expressed in cancerous colon cells and their methods of use ii
EP1307556A2 (en) 2000-08-03 2003-05-07 Corixa Corporation Compositions and methods for the therapy and diagnosis of colon cancer
WO2002012280A2 (en) 2000-08-03 2002-02-14 Corixa Corporation Compositions and methods for the therapy and diagnosis of colon cancer
US20030166064A1 (en) 2000-08-03 2003-09-04 Corixa Corporation Compositions and methods for the therapy and diagnosis of colon cancer
US20030077568A1 (en) 2000-09-15 2003-04-24 Gish Kurt C. Methods of diagnosis of colorectal cancer, compositions and methods of screening for colorectal cancer modulators
AU2001292802A1 (en) 2000-09-19 2002-04-02 Dana-Farber Cancer Institute Inc. Genetic markers for tumors
US20020150922A1 (en) 2000-11-20 2002-10-17 Corixa Corporation Compositions and methods for the therapy and diagnosis of colon cancer
US20030087818A1 (en) * 2001-02-02 2003-05-08 Corixa Corporation Compositions and methods for the therapy and diagnosis of colon cancer
CN1518604A (zh) * 2001-05-09 2004-08-04 克利夫兰大学医院 用新型基因标记、与之相关的方法和组合物来评测皮肤的紫外辐射损伤
US20030148314A1 (en) * 2001-08-01 2003-08-07 Millennium Pharmaceuticals, Inc. Compositions, kits, and methods for identification, assessment, prevention, and therapy of colon cancer
US7622260B2 (en) 2001-09-05 2009-11-24 The Brigham And Women's Hospital, Inc. Diagnostic and prognostic tests
EP1451340B1 (en) 2001-11-09 2014-01-08 Life Technologies Corporation Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles
US20030225526A1 (en) 2001-11-14 2003-12-04 Golub Todd R. Molecular cancer diagnosis using tumor gene expression signature
WO2003050243A2 (en) * 2001-12-10 2003-06-19 Millennium Pharmaceuticals Inc. Novel genes encoding colon cancer antigens
WO2003062395A2 (en) 2002-01-18 2003-07-31 Bristol-Myers Squibb Company Predictor sets for tyrosine kinase pathways
US7955800B2 (en) 2002-06-25 2011-06-07 Advpharma Inc. Metastasis-associated gene profiling for identification of tumor tissue, subtyping, and prediction of prognosis of patients
US20040053317A1 (en) 2002-09-10 2004-03-18 Sidney Kimmel Cancer Center Gene segregation and biological sample classification methods
WO2004110345A2 (en) 2002-10-29 2004-12-23 Pharmacia Corporation Differentially expressed genes involved in cancer, the polypeptides encoded thereby, and methods of using the same
PT1597391E (pt) 2003-02-20 2008-12-19 Genomic Health Inc Utilização de arn intrónico para medir a expressão genética
ES2905579T3 (es) 2003-07-10 2022-04-11 Genomic Health Inc Algoritmo del perfil de expresión y prueba para el pronóstico de la recaída del cáncer de mama
US20050014165A1 (en) 2003-07-18 2005-01-20 California Pacific Medical Center Biomarker panel for colorectal cancer
WO2005015236A2 (en) 2003-07-18 2005-02-17 Roche Diagnostics Gmbh A method for predicting the progression of adenocarcinoma
JP2007507204A (ja) * 2003-07-29 2007-03-29 ブリストル−マイヤーズ　スクイブ　カンパニー サイクリン依存性キナーゼモデュレーションのバイオマーカー
EP1522594A3 (en) 2003-10-06 2005-06-22 Bayer HealthCare AG Methods and kits for investigating cancer
WO2005076005A2 (en) 2004-01-30 2005-08-18 Medizinische Universität Wien A method for classifying a tumor cell sample based upon differential expression of at least two genes
US20060195266A1 (en) 2005-02-25 2006-08-31 Yeatman Timothy J Methods for predicting cancer outcome and gene signatures for use therein
EP1756301A4 (en) 2004-04-16 2008-01-23 Univ Monash METHOD FOR CONTROLLING PROGRESSION OF CANCER
WO2006010150A2 (en) 2004-07-15 2006-01-26 University Of Utah Research Foundation Housekeeping genes and methods for identifying the same
US20060183893A1 (en) 2005-01-25 2006-08-17 North Don A Nucleic acids for apoptosis of cancer cells
EP2083088A3 (en) 2005-04-07 2009-10-14 Novartis Vaccines and Diagnostics, Inc. Cancer-related genes
AU2006259583A1 (en) 2005-06-13 2006-12-28 The Regents Of The University Of Michigan Compositions and methods for treating and diagnosing cancer
EP1954708A4 (en) 2005-11-23 2009-05-13 Univ Utah Res Found METHODS AND COMPOSITIONS IN INTRINSIC GENES
US20090215054A1 (en) 2005-12-13 2009-08-27 Carter Scott L Prognosis indicators for solid human tumors
NZ544432A (en) 2005-12-23 2009-07-31 Pacific Edge Biotechnology Ltd Prognosis prediction for colorectal cancer using a prognositc signature comprising markers ME2 and FAS
NZ593228A (en) 2006-01-11 2012-10-26 Genomic Health Inc Gene expression markers (inhba) for colorectal cancer prognosis
WO2007112330A2 (en) 2006-03-24 2007-10-04 Diadexus, Inc. Compositions and methods for detection, prognosis and treatment of colon cancer
CA2680591A1 (en) 2007-03-15 2008-09-25 Genomic Health, Inc. Gene expression markers for prediction of patient response to chemotherapy
WO2009114836A1 (en) 2008-03-14 2009-09-17 Genomic Health, Inc. Gene expression markers for prediction of patient response to chemotherapy
US8765383B2 (en) 2009-04-07 2014-07-01 Genomic Health, Inc. Methods of predicting cancer risk using gene expression in premalignant tissue
SG175832A1 (en) 2009-05-01 2011-12-29 Genomic Health Inc Gene expression profile algorithm and test for likelihood of recurrence of colorectal cancer and response to chemotherapy

Also Published As

Publication number Publication date
WO2007082099A3 (en) 2008-01-17
US20100190173A1 (en) 2010-07-29
JP5297202B2 (ja) 2013-09-25
EP2412824A1 (en) 2012-02-01
US7695913B2 (en) 2010-04-13
EP1974058A2 (en) 2008-10-01
EP2377950B1 (en) 2014-09-17
CA2636984A1 (en) 2007-07-19
EP2412820A1 (en) 2012-02-01
US20090291434A1 (en) 2009-11-26
JP2013226151A (ja) 2013-11-07
NZ593229A (en) 2012-10-26
EP2412823B1 (en) 2014-09-03
US20130102492A1 (en) 2013-04-25
US20110039271A1 (en) 2011-02-17
JP5486719B2 (ja) 2014-05-07
AU2007204826A1 (en) 2007-07-19
US8198024B2 (en) 2012-06-12
EP2407553A1 (en) 2012-01-18
US20110111421A1 (en) 2011-05-12
US8153378B2 (en) 2012-04-10
EP2412823A1 (en) 2012-02-01
JP5486717B2 (ja) 2014-05-07
NZ593227A (en) 2012-10-26
US20110039269A1 (en) 2011-02-17
JP5486720B2 (ja) 2014-05-07
WO2007082099A2 (en) 2007-07-19
EP2412824B1 (en) 2014-10-08
US20110039270A1 (en) 2011-02-17
EP2400036A1 (en) 2011-12-28
JP2013226150A (ja) 2013-11-07
AU2007204826B2 (en) 2013-01-10
NO20083461L (no) 2008-10-10
JP2009523028A (ja) 2009-06-18
JP2013074894A (ja) 2013-04-25
US8026060B2 (en) 2011-09-27
US8367345B2 (en) 2013-02-05
EP2377950A1 (en) 2011-10-19
JP2013215201A (ja) 2013-10-24
NZ593225A (en) 2012-10-26
JP5486718B2 (ja) 2014-05-07
NZ569788A (en) 2011-08-26
EP2412822A1 (en) 2012-02-01
IL192794A0 (en) 2009-02-11
US20110097759A1 (en) 2011-04-28
BRPI0706511A2 (pt) 2011-03-29
IL192794A (en) 2013-07-31
NZ593228A (en) 2012-10-26
JP5486664B2 (ja) 2014-05-07
EP2412821B1 (en) 2014-09-17
EP2412821A1 (en) 2012-02-01
NZ593226A (en) 2012-10-26
JP2013176398A (ja) 2013-09-09
NZ593224A (en) 2012-10-26
US8153380B2 (en) 2012-04-10
US8273537B2 (en) 2012-09-25
DK1974058T3 (da) 2014-09-01
EP1974058B1 (en) 2014-06-11
US8153379B2 (en) 2012-04-10
ES2491222T3 (es) 2014-09-05
JP2013223503A (ja) 2013-10-31
KR20090003178A (ko) 2009-01-09
US8029995B2 (en) 2011-10-04
US20120171688A1 (en) 2012-07-05
MX2008008973A (es) 2008-11-26
US20110039272A1 (en) 2011-02-17

Similar Documents

Publication Publication Date Title
IL192794A0 (en) Gene expression markers for colorectal cancer prognosis
GB0625321D0 (en) Cancer biomarker
WO2008058018A8 (en) Predicting cancer outcome
EP2171453A4 (en) OVARIAN CANCER-FORECAST MARKER
EP2326734A4 (en) ROUTES OF PANCREATIC TUMORIGENESIS AND THE GENERIC GENE OF PANCREATIC CANCER
EP1934603A4 (en) BIOMARKER FOR PROSTATE CANCER
EP2024515A4 (en) METHYLATION OF GENES IN THE DIAGNOSIS OF CANCER
IL190382A0 (en) Detecting prostate cancer
EP2115162A4 (en) ADRB2-CANCER MARKER
IL193138A0 (en) Urine gene expression ratios for detection of cancer
EP2068618A4 (en) COMPOSITIONS AND METHODS OF DISCOVERING TUMOR GENES
EP2079839A4 (en) ASSESSMENT OF COLORECTAL CARCINOMA RISK
EP2046995A4 (en) SERUM DNA METHYLATION SCREENING FOR CANCER
IL186980A0 (en) Characterizing prostate cancer
EP2147298A4 (en) PROOF OF CANCER MARKERS
ZA200806316B (en) Gene expression markers for colorectal cancer prognosis
HK1108924A1 (en) Cancer prognostic methods
IL198354A0 (en) Genetic variations associated with tumors
EP2035439A4 (en) RISK ASSESSMENT FOR COLORECTAL CANCER
HK1115193A1 (zh) 與結腸癌有關的 因子
GB0714573D0 (en) Marker gene
EP2210099A4 (en) BIOMARKER FOR OVARIAL CARCINOMA
EP2236626A4 (en) GENOMIC FOOTPRINT FOR THE PROGNOSIS OF THE EVOLUTION OF A COLORECTAL ADENOCARCINOMA
GB0604231D0 (en) Cancer detection system
EP2083087A4 (en) METHOD FOR DETERMINING TONGUE CANCER

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20190108